KPV (10mg) vial
Currently unavailable

KPV

10mg Lyophilised Powder

$89.99AUD per vial

Concentration

10mg

Category

Repair Peptides

Volume Savings

1
Express shipping available Australia-wide
Independently laboratory tested with CoA available

Currently unavailable

Purity as reported on CoA: 99.234%

Frequently Bought Together

Retatrutide (10mg)

Support

Retatrutide (10mg)

$139.99

BPC-157 (10mg)

Support

BPC-157 (10mg)

$89.99

GLOW Peptide Blend (50mg)

Support

GLOW Peptide Blend (50mg)

$168.99

Product Information

The Gut Inflammation Peptide. Targeted. Fast. Without Broad Immune Suppression.

KPV (10mg) is available in Australia through Aus Peptide Supply with fast domestic shipping to all states and territories.

KPV is a tiny three-amino-acid peptide your body already produces naturally — derived from a hormone your immune system uses to regulate inflammation. What makes it interesting to researchers is how targeted it is: it calms inflammatory signals at the gut lining and skin barrier without broadly suppressing the immune system the way steroids and immunosuppressants do. That precision is what places it at the centre of gut inflammation research — particularly for models of IBD, Crohn's disease, and ulcerative colitis, where reducing mucosal inflammation without blunt immunosuppression is one of the core research challenges.

It also has a skin application: the same mechanism that calms gut inflammation is studied for accelerating wound healing, reducing inflammatory skin conditions, and restoring barrier function in damaged skin.

What KPV Is Studied For

  • Gut Inflammation — Studied for reducing mucosal inflammation in IBD, Crohn's disease, and ulcerative colitis research models
  • Gut Lining Repair — Supports healing of the intestinal barrier — the lining that keeps gut contents from leaking into the bloodstream
  • Skin Repair & Wound Healing — Accelerates epidermal healing and reduces inflammatory skin conditions through the same anti-inflammatory pathway
  • Targeted Immune Modulation — Turns down excessive inflammation without switching off the immune system broadly — a more precise approach than conventional immunosuppressants
  • Antimicrobial Activity — Demonstrated antimicrobial properties against bacterial and fungal pathogens in vitro

Supplied as lyophilized powder, verified by HPLC and mass spectrometry. 10mg per vial. Fast domestic shipping across Australia, with batch-specific CoA information available in our CoA Library.

⚠ For in-vitro research and laboratory use only. Not for human consumption.

Frequently Asked Questions

What is KPV?
KPV is a small peptide — just three amino acids — that your body produces naturally as part of its own anti-inflammatory system. It's derived from a hormone that regulates immune responses, and it retains that hormone's ability to calm inflammation in a far smaller, more stable form. What makes it stand out in the research community is its targeting: it reduces gut and skin inflammation without broadly suppressing the immune system — the main drawback of steroids and immunosuppressants.
Is KPV studied for IBD or Crohn's disease?
Yes — gut inflammation is where the majority of KPV research is focused. Studies have examined its ability to reduce mucosal inflammation in IBD, Crohn's disease, and ulcerative colitis models, as well as its role in repairing the gut lining after inflammatory damage. The research interest comes from its precision: it calms gut inflammation through targeted pathways rather than blunt immune suppression, which is the goal in gastrointestinal inflammation research.
How does KPV work?
KPV works by entering cells directly and dialling down the signals that drive inflammation — specifically the pathways that produce the cytokines responsible for gut and skin tissue damage. Unlike many anti-inflammatory approaches that broadly suppress immune function, KPV is studied for modulating specific inflammatory signals while leaving broader immune activity intact. That targeted action is why researchers studying IBD and skin repair find it interesting.
How does KPV differ from BPC-157?
BPC-157 is a broader repair peptide — studied across tendons, ligaments, muscle, gut, and nerves. KPV is more specific: its primary research application is gut and mucosal inflammation, with a secondary focus on skin. If the research question is gut inflammation specifically — IBD, Crohn's, ulcerative colitis — KPV is often the more targeted choice. If it's broader tissue repair that happens to include gut healing, BPC-157 is more commonly used.
How do you reconstitute KPV?
KPV is supplied as a lyophilized powder and should be reconstituted with bacteriostatic water (BAC water) immediately before use. Inject the BAC water slowly into the vial, directing the stream down the inside wall. Gently swirl to dissolve — do not shake. Once reconstituted, store at 2–8°C and use within 28 days. For a full step-by-step walkthrough, see our complete peptide reconstitution guide.
How should KPV be stored?
Store lyophilized KPV vials at -20°C, away from light and moisture. After reconstitution with BAC water, refrigerate at 2–8°C and use within 28 days. Do not freeze the reconstituted solution.
Where to buy KPV in Australia?
KPV (10mg) will be available through Aus Peptide Supply with fast domestic shipping to all Australian states and territories. Every vial is dispatched from within Australia, reducing delays linked to international freight and customs processing. Batch-specific Certificate of Analysis access will be available in our CoA library.
What is the availability and cost of KPV?
KPV (10mg) is currently out of stock at Aus Peptide Supply. KPV (10mg) is priced at $89.99 per vial at Aus Peptide Supply. All orders ship domestically within Australia, and batch CoAs are available in our CoA library.
How to get KPV online?
Once restocked, ordering is straightforward — add KPV (10mg) to your cart on the Aus Peptide Supply website and complete checkout through our secure payment system. All orders are fulfilled domestically and shipped with tracking to any address across Australia.